Abstract:Organismal aging has been associated with diverse metabolic and functional changes across tissues. Within the immune system, key features of physiological hematopoietic cell aging include increased fat deposition in the bone marrow, impaired hematopoietic stem and progenitor cell (HSPC) function, and a propensity towards myeloid differentiation. This shift in lineage bias can lead to pre-malignant bone marrow conditions such as clonal hematopoiesis of indeterminate potential (CHIP) or clonal cytopenias of undetermined significance (CCUS), frequently setting the stage for subsequent development of age-related cancers in myeloid or lymphoid lineages. At the systemic as well as sub-cellular level, human aging has also been associated with diverse lipid alterations, such as decreased phospholipid membrane fluidity that arises as a result of increased saturated fatty acid (FA) accumulation and a decay in n-3 polyunsaturated fatty acid (PUFA) species by the age of 80 years, however the extent to which impaired FA metabolism contributes to hematopoietic aging is less clear. Here, we performed comprehensive multi-omics analyses and uncovered a role for a key PUFA biosynthesis gene, , in mouse and human immune cell aging. Whole transcriptome RNA-sequencing studies of bone marrow from aged mutant (enzyme-deficient) mice compared with age-matched controls revealed global down-regulation in lymphoid cell markers and expression of genes involved specifically in B cell development. Flow cytometric analyses of immune cell markers confirmed an aging-associated loss of B cell markers that was exacerbated in the bone marrow of mutant mice and unveiled CD79B, a vital molecular regulator of lymphoid progenitor development from the pro-B to pre-B cell stage, as a putative surface biomarker of accelerated immune aging. Complementary lipidomic studies extended these findings to reveal select alterations in lipid species in aged and mutant mouse bone marrow samples, suggesting significant changes in the biophysical properties of cellular membranes. Furthermore, single cell RNA-seq analysis of human HSPCs across the spectrum of human development and aging uncovered a rare subpopulation (<7%) of CD34+ HSPCs that expresses in healthy adult bone marrow. This HSPC subset, along with -expressing lymphoid-committed cells, were almost completely absent in CD34+ cells isolated from elderly (>60 years old) bone marrow samples. Together, these findings uncover new roles for lipid metabolism enzymes in the molecular regulation of cellular aging and immune cell function in mouse and human hematopoiesis. In addition, because systemic loss of ELOVL2 enzymatic activity resulted in down-regulation of B cell genes that are also associated with lymphoproliferative neoplasms, this study sheds light on an intriguing metabolic pathway that could be leveraged in future studies as a novel therapeutic modality to target blood cancers or other age-related conditions involving the B cell lineage.

Immunometabolic effects of lactate on humoral immunity in healthy individuals of different ages

Immunometabolic Regulation of Vaccine-Induced Antibody Responses in Aging Mice

Metabolic requirements of human pro-inflammatory B cells in aging and obesity

Targeting Aging: Lessons Learned From Immunometabolism and Cellular Senescence

Defective respiration and one-carbon metabolism contribute to impaired naïve T cell activation in aged mice

Effects of Acute and Chronic Exercise on Immunological Parameters in the Elderly Aged: Can Physical Activity Counteract the Effects of Aging?

Crosstalk between glucose metabolism, lactate production and immune response modulation

Immunometabolic regulation of germinal centers and its implications for aging

Understanding the role of host metabolites in the induction of immune senescence: Future strategies for keeping the ageing population healthy

Lactate Exposure Promotes Immunosuppressive Phenotypes in Innate Immune Cells

Targeting age‐specific changes in CD4 + T cell metabolism ameliorates alloimmune responses and prolongs graft survival

The immunometabolic roots of aging

Enhanced mitochondrial function in B cells from elderly type-2 diabetes mellitus patients supports intrinsic inflammation

Effects of Lactate in Immunosuppression and Inflammation: Progress and Prospects

“Inflamm‐aging” influences immune cell survival factors in human bone marrow

In Vitro Treatment with Metformin Significantly Reduces Senescent B Cells Present in the Adipose Tissue of People with Obesity

Systemic deficits in lipid homeostasis promote aging-associated impairments in B cell progenitor development

Aging Induces an Nlrp3 Inflammasome-Dependent Expansion of Adipose B Cells That Impairs Metabolic Homeostasis

Obesity Accelerates Age-Associated Defects in Human B Cells Through a Metabolic Reprogramming Induced by the Fatty Acid Palmitate

B Cells Promote T Cell Immunosenescence and Mammalian Aging Parameters

Common And Distinct Metabolomic Markers Related To Immune Aging In Western European And East African Populations